article thumbnail

Fifteen years of subcutaneous implantable cardioverter-defibrillator therapy: Where do we stand, and what will the future hold?

HeartRhythm

The subcutaneous implantable cardioverter-defibrillator (S-ICD) has emerged as a feasible alternative for the transvenous ICD in the treatment of ventricular tachyarrhythmias in patients without pacing or cardiac resynchronization therapy indications.

article thumbnail

Injectable hydrogel electrodes open door to a novel painless treatment regimen for arrhythmia

Science Daily - Heart Disease

Such innovation in painless defibrillation and preventing arrhythmia could revolutionize cardiac rhythm management. The scientific advance is significant considering pain management is highly relevant to overall wellness for patients with heart, lung, and blood diseases.

article thumbnail

PO-03-176 FEASIBILITY OF LEFT BUNDLE BRANCH AREA DEFIBRILLATOR IMPLANTATION USING TRADITIONAL HIGH VOLTAGE LEADS

HeartRhythm

Left bundle branch area (LBBA) pacing is an innovative cardiac pacing technique, providing physiological stimulation, useful in patients affected by atrioventricular block, and rising as an effective alternative strategy to traditional cardiac resynchronization therapy.

article thumbnail

BS-469619-002 PHARMACOLOGIC RESCUE OF LOSS-OF-FUNCTION SCN5A CHANNELOPATHY

HeartRhythm

Because there is no disease-modifying therapeutic to date, the mainstay treatment remains the implantable cardioverter defibrillator, which is associated with significant adverse events.

article thumbnail

American Heart Association Announces New 2024-2025 National Volunteer Leaders

DAIC

I am excited as the organization moves into our second century and to embrace new and innovative strategies to expand our research and understanding of how we can ensure cardiovascular health and total health for all.” in Pittsburgh. During our second century we will continue to make health equity a priority across the globe.

article thumbnail

New Studies: AI Captures Electrocardiogram Patterns That Could Signal a Future Sudden Cardiac Arrest

DAIC

It cannot be treated with a defibrillator and often leads to death. Ventricular fibrillation is a type of irregular heartbeat that can cause the heart to stop beating, but an electric shock from a defibrillator can trigger the beating again.

article thumbnail

2024’s Mid-Year Review: FDA-Approved Cardiorenal Metabolic Drugs and Devices 

Cardiometabolic Health Congress

February 2024 FDA Approvals: Innovations in Cardiovascular Interventions XACT Carotid Stent System (Approved: 02/07/2024) This approval expands the indications to be used during a Transcarotid Artery Revascularization (TCAR) procedure to prevent future strokes.